Literature DB >> 3176972

A comparative distribution study of two procedures for administration of nose drops.

F Morén1, K Björnek, T Klint, Z G Wagner.   

Abstract

The intranasal distribution of nose drops has been studied in 12 healthy subjects, comparing an administration followed by two rapid inhalations through the nose, with an administration followed by turning the head to five positions. Insoluble particles of human serum albumin labelled with 99Tcm were suspended in the liquid before administration. A significantly larger area (p less than 0.05) in the nasal cavity was covered by the labelled nose drops when the subjects used the turning-the-head procedure. It appears that this procedure gave a larger passive distribution of the particles. The differences were about 10 to 15% between 3 and 45 min after administration. Some particles were rapidly transported into the pharynx. The retention of the particles at the initial site of deposition did not differ significantly between the two procedures and about 50% of the particles seemed to have penetrated to the ciliated region in the main nasal passages and were cleared. The results indicate that the procedure for administration of the nose drops influences the distribution in the nasal cavity, but the clinical relevance should be studied with respect to the efficacy of the active drug in patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3176972     DOI: 10.3109/00016488809106438

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  2 in total

1.  Influence of anatomy and head position on intranasal drug deposition.

Authors:  Paul Merkus; Fenna A Ebbens; Barbara Muller; Wytske J Fokkens
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-06-29       Impact factor: 2.503

Review 2.  Update on Intranasal Medications in Rhinosinusitis.

Authors:  Kornkiat Snidvongs; Sanguansak Thanaviratananich
Journal:  Curr Allergy Asthma Rep       Date:  2017-07       Impact factor: 4.806

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.